4-[3-(Trifluoromethyl)phenyl]piperidin-4-ol hydrochloride, 97.0%, 5g

Methyl 4-(cyclopropylamino)-3-nitrobenzoate, 95.0%, 1g

TERT-BUTYL (4R,6R)-2-[6-[2-[2-(4-FLUOROPHENYL)-5-ISOPROPYL-3-PHENYL-4-(PHENYLCARBAMOYL)PYRROL-1-YL]ETHYL]-2,2-DIMETHYL-1,3-DIOXAN-4-YL]ACETATE, 98%, 500g

2-[2-(Dicyclohexylphosphino)phenyl]-1-methyl-1H-indole, 97%, 1g

5-(Bromomethyl)-2-fluoropyridine, 95.0%, 1g

(Z)-METHYL 2-BROMOBUT-2-ENOATE, 95.0%, 5g

Sodium phosphinate monohydrate, min. 99%, ultra pure, 500 g, plastic packaging.

5,10-Dihydroindolo[3,2-b]indole, 95.0%, 10g

3-(1,3,4-Oxadiazol-2-yl)benzene-1-sulfonamide, 95%, 250mg

(3S)-8-fLuoro-1-methyl-3-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2,4(1h,3h)-quinazolinedione, 98%, 100mg

Cryo labels Cryo-Clear, 24 x 13 mm, Gesch. for, 0.5 ml vials, 20 pieces

2'-Chloro-2,2,2-trifluoroacetophenone, 95.0%, 250mg

3-amino-1-tert-butyl-4,5-dihydro-1H-pyrazol-5-one, 95%, 100mg